Washington, DC - A new analysis of data from the landmark Diabetes Control and Complications Trial and the ongoing follow-up Epidemiology of Diabetes Interventions and Complications Study (DCCT ...

More information: Boris P. Kovatchev et al, The Virtual DCCT: Adding Continuous Glucose Monitoring to a Landmark Clinical ...

The Virtual DCCT: Adding Continuous Glucose Monitoring to a Landmark Clinical Trial for Prediction of Microvascular Complications. Diabetes Technology & Therapeutics , 2025; DOI: 10.1089/dia.2024.0404 ...

The landmark Diabetes Control and Complications Trial (DCCT) funded by the National Institutes of Health, which followed 1,441 people with type 1 diabetes for a decade until 1993, showed ...

The research study, published in Jan. 2025, analyzed data from the landmark Diabetes Control and Complications Trial (DCCT) — a 10-year study involving 1,440 participants.

"The landmark 10-year, 1,440-person Diabetes Control and Complications Trial (DCCT), published in 1993, established hemoglobin A1c as the gold standard for evaluating the risk for complications ...

Research outputs, collaborations and relationships for Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) ...

The EDIC trial enrolled 1,388 patients (96% of the original DCCT cohort). Patients were assessed annually using the Michigan Neuropathy Screening Instrument (MNSI), which consists of a self ...

Intensive control of blood glucose levels in patients with type 1 diabetes mellitus (T1DM) has long-term effects on kidney function. In the DCCT trial, patients with T1DM were randomly assigned to ...

The Diabetes Control and Complications Trial (DCCT) and the subsequent Epidemiology of Diabetes Control and Complications (EDIC) observational study have significantly changed treatment protocols ...